Xylem Inc (XYL) financial statements: income statement, balance sheet and cash flow
Xylem Inc's income statement, balance sheet and cash flow statement as filed with the SEC (10-K and 10-Q), with the latest fiscal years and quarters. In its latest fiscal year (Dec 31, 2025 · FY), Xylem Inc reported revenue of $9.0B (+5.5% year on year) and net income of $957.0M.
Income statement
Xylem Inc income statement, fiscal years
Line item
Dec 31, 2025 · FY
Dec 31, 2024 · FY
Dec 31, 2023 · FY
Dec 31, 2022 · FY
Revenue
$9.0B
$8.6B
$7.4B
$5.5B
Cost of revenue
$5.6B
$5.3B
$4.6B
$3.4B
Gross profit
$3.5B
$3.2B
$2.7B
$2.1B
Selling, general and administrative expenses
$1.9B
$1.9B
$1.8B
$1.2B
Research and development expenses
$226.0M
$230.0M
$232.0M
$206.0M
Restructuring and asset impairment charges
$103.0M
$62.0M
$76.0M
$29.0M
Operating income
$1.2B
$1.0B
$652.0M
$622.0M
Interest expense
($29.0M)
$44.0M
$49.0M
$50.0M
Gain on remeasurement of previously held equity interest
$0
$152.0M
—
—
Other non-operating income, net
$18.0M
$16.0M
$33.0M
$7.0M
Loss on sale of businesses
($31.0M)
($46.0M)
($1.0M)
$1.0M
Income before taxes
$1.2B
$1.1B
$635.0M
$440.0M
Income tax expense
($231.0M)
$197.0M
$26.0M
$85.0M
Net income
$950.0M
$890.0M
$609.0M
$355.0M
Net loss attributable to non-controlling interests
$7.0M
—
—
—
Net income attributable to Xylem
$957.0M
—
—
—
Basic (in dollars per share)
$3.93
$3.67
$2.81
$1.97
Diluted (in dollars per share)
$3.92
$3.65
$2.79
$1.96
Basic (in shares)
243.4M
242.6M
217.0M
180.2M
Diluted (in shares)
244.0M
243.5M
218.2M
181.0M
Xylem Inc income statement, quarters
Line item
Jun 30, 2026 · Q2
Mar 31, 2026 · Q1
Sep 30, 2025 · Q3
Jun 30, 2025 · Q2
Revenue
$2.3B
$2.1B
$2.3B
$2.3B
Cost of revenue
$1.4B
$1.3B
$1.4B
$1.4B
Gross profit
$963.0M
$803.0M
$883.0M
$892.0M
Selling, general and administrative expenses
$503.0M
$472.0M
$474.0M
$503.0M
Research and development expenses
$59.0M
$56.0M
$52.0M
$58.0M
Restructuring and asset impairment charges
$11.0M
$31.0M
$23.0M
$26.0M
Operating income
$390.0M
$244.0M
$334.0M
$305.0M
Interest expense
($7.0M)
($4.0M)
($6.0M)
($9.0M)
Other non-operating (expense)/income, net
($3.0M)
$0
$6.0M
$3.0M
Loss on sale of businesses
($16.0M)
$4.0M
($37.0M)
$0
Income before taxes
$364.0M
$244.0M
$297.0M
$299.0M
Income tax expense
($103.0M)
($55.0M)
($71.0M)
($75.0M)
Net income
$261.0M
$189.0M
$226.0M
$224.0M
Net loss attributable to non-controlling interests
$2.0M
$4.0M
$1.0M
$2.0M
Net income attributable to Xylem
$263.0M
$193.0M
$227.0M
$226.0M
Basic (usd per share)
$1.11
$0.79
$0.93
$0.93
Diluted (usd per share)
$1.11
$0.79
$0.93
$0.93
Basic (in shares)
236.3M
242.8M
243.5M
243.4M
Diluted (in shares)
236.6M
243.4M
244.1M
243.9M
Balance sheet
Xylem Inc balance sheet, fiscal years
Line item
Dec 31, 2025 · FY
Dec 31, 2024 · FY
Dec 31, 2023 · FY
Dec 31, 2022 · FY
Cash and cash equivalents
$1.5B
$1.1B
$1.0B
$944.0M
Receivables, less allowances for discounts, returns and credit losses of $68 and $59 in 2025 and 2024, respectively
$1.8B
$1.7B
$1.6B
$1.1B
Inventories
$983.0M
$996.0M
$1.0B
$799.0M
Prepaid and other current assets
$244.0M
$236.0M
$230.0M
$173.0M
Assets held for sale
$176.0M
$77.0M
—
—
Total current assets
$4.6B
$4.1B
$3.9B
$3.0B
Property, plant and equipment, net
$1.2B
$1.2B
$1.2B
$630.0M
Goodwill
$8.3B
$8.0B
$7.6B
$2.7B
Other intangible assets, net
$2.3B
$2.4B
$2.5B
$930.0M
Other non-current assets
$1.2B
$884.0M
$943.0M
$661.0M
Total assets
$17.6B
$16.5B
$16.1B
$8.0B
Accounts payable
$1.0B
$1.0B
$968.0M
$723.0M
Accrued and other current liabilities
$1.2B
$1.3B
$1.2B
$867.0M
Short-term borrowings and current maturities of long-term debt
$534.0M
$38.0M
$16.0M
—
Liabilities held for sale
$72.0M
$21.0M
—
—
Total current liabilities
$2.9B
$2.3B
$2.2B
$1.6B
Long-term debt, net
$1.4B
$2.0B
$2.3B
$1.9B
Accrued post-retirement benefit obligations
$317.0M
$304.0M
$344.0M
$286.0M
Deferred income tax liabilities
$405.0M
$497.0M
$557.0M
$222.0M
Other non-current accrued liabilities
$899.0M
$496.0M
$562.0M
$471.0M
Total liabilities
$5.9B
$5.6B
$5.9B
$4.4B
Redeemable non-controlling interest
$258.0M
$235.0M
—
—
Authorized 750.0 shares, issued 259.9 and 259.2 shares in 2025 and 2024, respectively
3.0M
3.0M
3.0M
2.0M
Capital in excess of par value
$8.8B
$8.7B
$8.6B
$2.1B
Retained earnings
$3.7B
$3.1B
$2.6B
$2.3B
Treasury stock – at cost 16.3 shares and 16.2 shares in 2025 and 2024, respectively
-768.0M
-753.0M
-733.0M
-708.0M
Accumulated other comprehensive loss
($220.0M)
($435.0M)
($269.0M)
($226.0M)
Total stockholders’ equity
$11.5B
$10.6B
$10.2B
$3.5B
Non-controlling interest
$11.0M
$5.0M
$10.0M
$9.0M
Total equity
$11.5B
$10.6B
$10.2B
$3.5B
Total liabilities, redeemable non-controlling interest, and stockholders’ equity
$17.6B
$16.5B
$16.1B
$8.0B
Xylem Inc balance sheet, quarters
Line item
Jun 30, 2026
Mar 31, 2026
Sep 30, 2025
Jun 30, 2025
Cash and cash equivalents
$1.3B
$808.0M
$1.2B
$1.2B
Receivables, less allowances for discounts, returns and credit losses of $54 and $68 in 2026 and 2025, respectively
$1.9B
$1.8B
$1.8B
$1.8B
Inventories
$1.0B
$991.0M
$1.0B
$1.1B
Prepaid and other current assets
$219.0M
$243.0M
$254.0M
$283.0M
Assets held for sale
$8.0M
$192.0M
$158.0M
$8.0M
Total current assets
$4.4B
$4.0B
$4.4B
$4.4B
Property, plant and equipment, net
$1.2B
$1.2B
$1.1B
$1.2B
Goodwill
$8.3B
$8.3B
$8.3B
$8.2B
Other intangible assets, net
$2.1B
$2.2B
$2.3B
$2.4B
Other non-current assets
$1.4B
$1.3B
$1.1B
$1.0B
Total assets
$17.3B
$17.0B
$17.3B
$17.2B
Accounts payable
$1.0B
$969.0M
$968.0M
$1.0B
Accrued and other current liabilities
$1.2B
$1.2B
$1.2B
$1.2B
Short-term borrowings and current maturities of long-term debt
$531.0M
$531.0M
$49.0M
$68.0M
Liabilities held for sale
$0
$73.0M
$80.0M
$0
Total current liabilities
$2.7B
$2.8B
$2.3B
$2.3B
Long-term debt
$2.4B
$1.4B
$1.9B
$1.9B
Accrued post-retirement benefit obligations
$301.0M
$308.0M
$323.0M
$340.0M
Deferred income tax liabilities
$446.0M
$437.0M
$492.0M
$427.0M
Other non-current accrued liabilities
$810.0M
$818.0M
$853.0M
$886.0M
Total liabilities
$6.7B
$5.7B
$5.8B
$5.9B
Redeemable non-controlling interest
$242.0M
$249.0M
$226.0M
$228.0M
Authorized 750.0 shares, issued 260.3 shares and 259.9 shares in 2026 and 2025, respectively
3.0M
3.0M
3.0M
3.0M
Capital in excess of par value
$8.8B
$8.8B
$8.7B
$8.7B
Retained earnings
$4.0B
$3.8B
$3.5B
$3.3B
Treasury stock – at cost 26.8 shares and 16.3 shares in 2026 and 2025, respectively
-2.0B
-1.4B
-767.0M
-766.0M
Accumulated other comprehensive loss
($302.0M)
($229.0M)
($233.0M)
($222.0M)
Total stockholders’ equity
$10.4B
$11.0B
$11.2B
$11.1B
Non-controlling interests
$3.0M
$8.0M
$12.0M
$7.0M
Total equity
$10.4B
$11.0B
$11.2B
$11.1B
Total liabilities, redeemable non-controlling interest, and stockholders’ equity
$17.3B
$17.0B
$17.3B
$17.2B
Cash flow statement
Xylem Inc cash flow statement, fiscal years
Line item
Dec 31, 2025 · FY
Dec 31, 2024 · FY
Dec 31, 2023 · FY
Dec 31, 2022 · FY
Net income
$950.0M
$890.0M
$609.0M
$355.0M
Depreciation
$267.0M
$258.0M
$193.0M
$111.0M
Amortization
$308.0M
$304.0M
$243.0M
$125.0M
Deferred income taxes
($35.0M)
($36.0M)
($79.0M)
($64.0M)
Share-based compensation
$53.0M
$56.0M
$60.0M
$37.0M
Restructuring and asset impairment charges
$103.0M
$62.0M
$76.0M
$29.0M
Loss from sale of businesses
$31.0M
$46.0M
$1.0M
($1.0M)
Gain on remeasurement of previously held equity interest
$0
($152.0M)
—
—
Other, net
$5.0M
$4.0M
$0
($4.0M)
Payments for restructuring
($82.0M)
($32.0M)
($30.0M)
($11.0M)
Contributions to post-retirement benefit plans
($26.0M)
($25.0M)
($25.0M)
($19.0M)
Changes in receivables
($55.0M)
($107.0M)
($87.0M)
($192.0M)
Changes in inventories
$23.0M
($41.0M)
$41.0M
($147.0M)
Changes in accounts payable
($22.0M)
$64.0M
$22.0M
$117.0M
Changes in accrued liabilities
($69.0M)
$17.0M
($4.0M)
$57.0M
Changes in accrued and deferred taxes
$0
$14.0M
($109.0M)
$57.0M
Changes in long term receivables
($146.0M)
—
—
—
Net changes in other assets and liabilities
($64.0M)
($59.0M)
($74.0M)
$6.0M
Net Cash — Operating activities
$1.2B
$1.3B
$837.0M
$596.0M
Capital expenditures
($331.0M)
($321.0M)
($271.0M)
($208.0M)
Proceeds from the sale of property, plant and equipment
$17.0M
$4.0M
$1.0M
—
Acquisitions of businesses, net of cash acquired
($163.0M)
($193.0M)
($476.0M)
—
Proceeds from sale of businesses, net of cash disposed
$49.0M
$11.0M
$105.0M
$1.0M
Cash received from investments
$8.0M
$6.0M
$1.0M
$8.0M
Cash paid for investments
($49.0M)
($11.0M)
($1.0M)
($11.0M)
Cash received from interest rate swaps
$0
$0
$38.0M
—
Cash received from cross-currency swaps
$35.0M
$29.0M
$28.0M
$28.0M
Cash paid for asset acquisition
($37.0M)
$0
$0
($10.0M)
Other, net
$0
($1.0M)
$4.0M
$1.0M
Net Cash — Investing activities
($471.0M)
($482.0M)
($628.0M)
($191.0M)
Short-term debt issued, net
$1.0M
—
—
$0
Short-term debt repaid
$0
($268.0M)
—
$0
Long-term debt issued, net
$0
$1.0M
$278.0M
$0
Long-term debt repaid, net
($82.0M)
($17.0M)
($160.0M)
($527.0M)
Repurchase of common stock
($15.0M)
($20.0M)
($25.0M)
($52.0M)
Proceeds from exercise of employee stock options
$20.0M
$67.0M
$62.0M
$8.0M
Dividends paid
($391.0M)
($350.0M)
($299.0M)
($217.0M)
Other, net
($34.0M)
($28.0M)
($13.0M)
($2.0M)
Net Cash — Financing activities
($501.0M)
($615.0M)
($157.0M)
($790.0M)
Effect of exchange rate changes on cash
$90.0M
($53.0M)
$23.0M
($20.0M)
Increase in cash classified within assets held for sale
($12.0M)
—
—
—
Decrease in cash classified within assets held for sale
$11.0M
—
—
—
Cash classified within assets held for sale
($1.0M)
($11.0M)
—
—
Net change in cash and cash equivalents
$358.0M
$102.0M
$75.0M
($405.0M)
Cash and cash equivalents at beginning of year
$1.1B
$1.0B
$944.0M
$1.3B
Xylem Inc cash flow statement, quarters
Line item
Jun 30, 2026 · YTD
Mar 31, 2026 · Q1
Sep 30, 2025 · YTD
Jun 30, 2025 · YTD
Net income
$450.0M
$189.0M
$617.0M
—
Net income attributable to Xylem
$456.0M
$193.0M
—
$395.0M
Depreciation
$130.0M
$65.0M
$201.0M
$137.0M
Amortization
$150.0M
$75.0M
$231.0M
$153.0M
Share-based compensation
$25.0M
$13.0M
$37.0M
$25.0M
Restructuring and asset impairment charges
$42.0M
$31.0M
$70.0M
$47.0M
Loss on sale of businesses
($12.0M)
$4.0M
($47.0M)
($10.0M)
Other, net
($27.0M)
($8.0M)
$3.0M
$6.0M
Payments for restructuring
($49.0M)
($37.0M)
($48.0M)
($36.0M)
Changes in receivables
($142.0M)
($58.0M)
($113.0M)
($103.0M)
Changes in inventories
$41.0M
($18.0M)
($30.0M)
($27.0M)
Changes in accrued expenses
($13.0M)
—
—
—
Changes in accrued and deferred taxes
$1.0M
—
($12.0M)
($50.0M)
Other, net
($36.0M)
($48.0M)
($260.0M)
($225.0M)
Changes in long term receivables
($104.0M)
($31.0M)
—
—
Net Cash – Operating activities
$398.0M
$108.0M
$698.0M
$338.0M
Capital expenditures
($179.0M)
($90.0M)
($248.0M)
($169.0M)
Acquisitions of businesses, net of cash acquired
($1.0M)
$0
($113.0M)
($7.0M)
Proceeds from sale of businesses, net of cash disposed
$59.0M
$0
$48.0M
$50.0M
Proceeds from the sale of property, plant and equipment
$11.0M
$1.0M
$15.0M
$5.0M
Cash paid for investments
($3.0M)
$0
($26.0M)
$0
Cash paid for asset acquisition
($2.0M)
($1.0M)
($37.0M)
($37.0M)
Cash received from cross-currency swaps
$17.0M
$14.0M
$31.0M
$21.0M
Net Cash – Investing activities
($98.0M)
($76.0M)
($329.0M)
($140.0M)
Short-term debt issued, net
$0
$0
$1.0M
$4.0M
Long-term debt issued, net
$990.0M
—
—
—
Long-term debt repaid
($6.0M)
($4.0M)
($60.0M)
($28.0M)
Repurchase of common stock
($1.2B)
($563.0M)
($14.0M)
($13.0M)
Proceeds from exercise of employee stock options
$2.0M
$0
$11.0M
$8.0M
Dividends paid
($207.0M)
($106.0M)
($293.0M)
($196.0M)
Other, net
($20.0M)
$0
$1.0M
$0
Net Cash – Financing activities
($484.0M)
($683.0M)
($382.0M)
($244.0M)
Effect of exchange rate changes on cash
($31.0M)
($15.0M)
$83.0M
$84.0M
Increase in cash classified within assets held for sale
$0
($5.0M)
$11.0M
—
Decrease in cash classified within assets held for sale
$12.0M
$0
($11.0M)
—
Changes in cash classified within assets held for sale